Kiliç Abdullah, Bedir Orhan, Tunç Turan, Beşirbellioğlu Bülent, Eyigün Can Polat, Başustaoğlu Ahmet Celal
Gülhane Askeri Tip Fakültesi, Mikrobiyoloji ve Klinik Mikrobiyoloji Anabilim Dali, Ankara.
Mikrobiyol Bul. 2009 Jul;43(3):365-72.
Vancomycin-resistant enterococci (VRE) have been increasingly reported from most countries around the world following initial isolation from patients in United States and European countries. A vancomycin-resistant Enterococcus faecium (VREF) outbreak was determined by hospital infection control committee in the pediatric unit of Gulhane Military Medical Academy, Ankara, Turkey in the first week of March 2008. While one of the 4 VREF strains was isolated from urine culture of a patient with neuroblastoma, the remaining strains were isolated from cultures of urine and rectal swab samples of a patient with nephrotic syndrome and from the hospital room doorknob of this patient. Aims of this study were to determine antibiotic susceptibilities by E-test, to investigate the presence of vanA, vanB and vanC-2 resistance genes by polymerase chain reaction (PCR), and to genotype the 4 strains by pulsed field gel electrophoresis (PFGE) and repetitive PCR (rep-PCR) (DiversiLab, bioMérieux, France). All isolates conferred high level [minimum inhibitor concentration (MIC) > 256 mg/L] vancomycin and teicoplanin resistance by E-test method. The isolates were also found resistant to gentamicin, streptomycin, ampicillin, erythromycin, penicillin and were susceptible to tetracycline and linezolid. The vanA gene was detected in all strains by PCR. It was demonstrated that the 4 VRE strains belonged to a single clone as shown by both PFGE and rep-PCR methods. Prompt and accurate detection of VRE and determination of the genotypes is of crucial importance to prevent horizontal transfer of the strains in the hospital. When compared with PFGE, the DiversiLab commercial rep-PCR seems to be a reliable and more rapid method to detect the genetic relationship between strains leading to an outbreak.
自美国和欧洲国家首次从患者中分离出耐万古霉素肠球菌(VRE)以来,世界上大多数国家对其的报道日益增多。2008年3月的第一周,土耳其安卡拉的古尔汗军事医学院儿科病房的医院感染控制委员会确定发生了耐万古霉素屎肠球菌(VREF)暴发。4株VREF菌株中的1株是从一名神经母细胞瘤患者的尿培养物中分离出来的,其余菌株则分别从一名肾病综合征患者的尿培养物和直肠拭子样本以及该患者病房的门把手上分离得到。本研究的目的是通过E试验确定抗生素敏感性,通过聚合酶链反应(PCR)研究vanA、vanB和vanC - 2耐药基因的存在情况,并通过脉冲场凝胶电泳(PFGE)和重复PCR(rep-PCR)(法国生物梅里埃公司的DiversiLab)对这4株菌株进行基因分型。通过E试验方法,所有分离株对万古霉素和替考拉宁均表现出高水平耐药[最低抑菌浓度(MIC)> 256 mg/L]。这些分离株还对庆大霉素、链霉素、氨苄西林、红霉素、青霉素耐药,对四环素和利奈唑胺敏感。通过PCR在所有菌株中均检测到vanA基因。PFGE和rep-PCR方法均显示,这4株VRE菌株属于单一克隆。及时、准确地检测VRE并确定其基因型对于防止医院内菌株的水平传播至关重要。与PFGE相比,DiversiLab商业rep-PCR似乎是一种可靠且更快速的方法,可用于检测导致暴发的菌株之间的遗传关系。